Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1013243/000095014405011526/g96816q1e10vq.htm
January 2006
November 2005
August 2005
August 2005
July 2005
July 2005
June 2005
May 2005
May 2005
Delaware | 0-21185 | 04-2687849 | ||
(State or Other Jurisdiction | (Commission File Number) | (I.R.S. Employer | ||
of Incorporation) | Identification No.) |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1013243/000095014405011526/g96816q1e10vq.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Aaipharma Inc.
Aaipharma Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2005 10-K Annual Report includes:
CIK: 1013243
Form Type: 10-Q Quarterly Report
Accession Number: 0000950144-05-011526
Submitted to the SEC: Wed Nov 09 2005 4:41:57 PM EST
Accepted by the SEC: Wed Nov 09 2005
Period: Thursday, June 30, 2005
Industry: Testing Laboratories